Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer

APCEDEN®, APAC's immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors (GBM) and pancreatic cancers (PDAC) with its new technology. DELHI, India, July 23, 2020 /...

2020-07-23 22:00 2886

Clarity Pharmaceuticals opens SARTATE neuroblastoma clinical trial

SYDNEY, July 23, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has opened its trial of67Cu-SARTATE™ for paediatric patients with neuroblastoma at Memorial Sloan Kettering Cancer Center (MSK) ...

2020-07-23 21:13 2014

N.B. Quadriga's Transformative Treatment for Brain Cancers Dosed in First Human Subject

SHANGHAI and NANTONG, China, July 23, 2020 /PRNewswire/ -- N.B. Quadriga (NBQ), a clinical stage biopharmaceutical company developing transformative medicines for brain cancers, today announced that the first patient has been dosed in a Phase 1 study of NBQ72S, also known as QBS10072S, in pati...

2020-07-23 19:00 3854

Zhongchao Inc. Joined Hands with Professional Non-Profit Organizations and 9 Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cancer

SHANGHAI, July 23, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it joined hands with China Health P...

2020-07-23 18:30 4117

InnoTier launched new sustainable and innovative products in Hong Kong amid COVID-19 pandemic

HONG KONG, July 23, 2020 /PRNewswire/ -- InnoTier, the lifestyle consumer brand under Julius Group, has announced to launch four innovative products inHong Kong with the aim of enabling people to lead more sustainable lives in a rapidly changing world. Against the backdrop of the current global p...

2020-07-23 14:06 7810

InnoTier launched new sustainable and innovative products in Hong Kong amid COVID-19 pandemic

Bupa Global Research finds Hong Kong and Mainland China senior executives increasingly concerned about health issues

* A majority of senior executives in Hong Kong (87.6%) and Mainland China (70.5%) have experienced physical and mental health pressure amid the outbreak of COVID-19, but less than 9% seeking professional support * Only 32% and 25.2% of Hong Kong senior executives stated financial stability, and...

2020-07-22 17:38 4179

Ascentage Pharma Announces First Patient Dosed in the Phase Ib Study of MDM2-p53 Inhibitor APG-115 as Single Agent and in Combinations for the Treatment of Hematologic Malignancies in China

SUZHOU, China and ROCKVILLE, Md., July 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase Ib study of t...

2020-07-22 17:31 2245

Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test

SAN DIEGO and SHANGHAI, July 21, 2020 /PRNewswire/ -- Fudan University's Taizhou Health Science Institute and Singlera Genomics, focused on non-invasive early cancer detection, today announce the publication of a peer reviewed manuscript demonstrating the initial results from the Taizhou Longitud...

2020-07-21 23:00 1962

Surgere: AutoSphere Gains Altitude - Faster Than Ever

CLEVELAND and TOKYO and ANTWERP, Belgium and AGUASCALIENTES, Mexico, July 21, 2020 /PRNewswire/ -- The Surgere Automotive Supply Chain Community has reached record numbers. The community's amazing growth includes 136 sites in theNorth America and 64 sites in Asia Pacific since January 2020. AutoS...

2020-07-21 22:07 3549

GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and ...

2020-07-21 22:04 2659

Ortho Care(TM) Again Ranks No. 1 for Service in Diagnostics Industry

RARITAN, N.J., July 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked No. 1 in the diagnostics in...

2020-07-21 22:00 2808

Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets

SYDNEY and LOS ANGELES, July 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop n...

2020-07-21 21:13 2052

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

World's first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings FREMONT, Calif., July 21, 2020 /PRNewswire/ -- LifeSignals Group, today announced USFDA 510(k) clearance has been received for ...

2020-07-21 19:00 4290

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

NICHIBAN to Establish European Subsidiary "NICHIBAN EUROPE GmbH" in Germany

TOKYO, July 21, 2020 /PRNewswire/ -- NICHIBAN CO., LTD., based in Tokyo, announced that it will open a new European subsidiary, "NICHIBANEUROPE GmbH" in Dusseldorf, Germany, in October 2020. As part of the expansion of the company's overseas business, NICHIBAN opened a representative office inDu...

2020-07-21 13:00 1925

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

SONGDO, South Korea, July 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced a plan to expand its Drug Product (DP) capability in line with increasing market demand and to ensure flexible production capabilities for new and existing clients.

2020-07-21 10:13 15996

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

D-Link Launches Group Temperature Screening Camera Kit with AI Facial Recognition

TAIPEI, July 20, 2020 /PRNewswire/ -- D-Link today announced the new DCS-9500T Group Temperature Screening Camera Kit that can simultaneously scan up to 30 people with a rapid response time within 30 ms, eliminating queues i...

2020-07-21 10:00 2180

D-Link Launches Group Temperature Screening Camera Kit with AI Facial Recognition

TAIPEI, July 21, 2020 /PRNewswire/ -- D-Link today announced the new DCS-9500T Group Temperature Screening Camera Kit that can simultaneously scan up to 30 people with a rapid response time within 30 ms, eliminating queues i...

2020-07-21 10:00 2628

China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor

SHANGHAI and SAN FRANCISCO and WALTHAM, Mass., July 20, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB) and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for ripretinib...

2020-07-20 22:39 4712

JW Therapeutics Acquires Syracuse Biopharma and Its in-Licenses With Eureka Therapeutics' Solid Tumor Technologies in China

SHANGHAI and EMERYVILLE, Calif., July 20, 2020 /PRNewswire/ -- JW Therapeutics , a clinical stage biopharmaceutical company focused on developing, manufacturing and commercializing cell therapies for patients inChina, today announced the acquisition of Syracuse Bio...

2020-07-20 21:33 4586

PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit

GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European...

2020-07-20 21:00 1999

1 ... 547 548 549550551 552 553 ... 608